
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bacteriophage Therapy: Developments and Directions
Mikeljon P. Nikolich, Andrey A. Filippov
Antibiotics (2020) Vol. 9, Iss. 3, pp. 135-135
Open Access | Times Cited: 126
Mikeljon P. Nikolich, Andrey A. Filippov
Antibiotics (2020) Vol. 9, Iss. 3, pp. 135-135
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2879-2898.e24
Open Access | Times Cited: 311
Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2879-2898.e24
Open Access | Times Cited: 311
Combating Implant Infections: Shifting Focus from Bacteria to Host
Saber Amin Yavari, Suzanne M. Castenmiller, Jos A. G. van Strijp, et al.
Advanced Materials (2020) Vol. 32, Iss. 43
Open Access | Times Cited: 185
Saber Amin Yavari, Suzanne M. Castenmiller, Jos A. G. van Strijp, et al.
Advanced Materials (2020) Vol. 32, Iss. 43
Open Access | Times Cited: 185
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth
Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1019-1019
Open Access | Times Cited: 127
Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1019-1019
Open Access | Times Cited: 127
The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies
Fusheng Zhang, Wei Cheng
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1215-1215
Open Access | Times Cited: 98
Fusheng Zhang, Wei Cheng
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1215-1215
Open Access | Times Cited: 98
Understanding Bacteriophage Tail Fiber Interaction with Host Surface Receptor: The Key “Blueprint” for Reprogramming Phage Host Range
Jarin Taslem Mourosi, Ayobami Awe, Wenzheng Guo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12146-12146
Open Access | Times Cited: 89
Jarin Taslem Mourosi, Ayobami Awe, Wenzheng Guo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12146-12146
Open Access | Times Cited: 89
Antibiotic resistance: a global crisis, problems and solutions
Rupesh Aggarwal, Pooja Mahajan, Sameeksha Pandiya, et al.
Critical Reviews in Microbiology (2024) Vol. 50, Iss. 5, pp. 896-921
Closed Access | Times Cited: 28
Rupesh Aggarwal, Pooja Mahajan, Sameeksha Pandiya, et al.
Critical Reviews in Microbiology (2024) Vol. 50, Iss. 5, pp. 896-921
Closed Access | Times Cited: 28
Salmonella in Chicken Meat: Consumption, Outbreaks, Characteristics, Current Control Methods and the Potential of Bacteriophage Use
Kirsten Wessels, Diane Rip, Pieter A. Gouws
Foods (2021) Vol. 10, Iss. 8, pp. 1742-1742
Open Access | Times Cited: 94
Kirsten Wessels, Diane Rip, Pieter A. Gouws
Foods (2021) Vol. 10, Iss. 8, pp. 1742-1742
Open Access | Times Cited: 94
Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains
Carlos A. Guerrero-Bustamante, Rebekah M. Dedrick, Rebecca A. Garlena, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 88
Carlos A. Guerrero-Bustamante, Rebekah M. Dedrick, Rebecca A. Garlena, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 88
Treatment of Wound Infections in a Mouse Model Using Zn2+-Releasing Phage Bound to Gold Nanorods
Huan Peng, Daniele Rossetto, Sheref S. Mansy, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4756-4774
Open Access | Times Cited: 67
Huan Peng, Daniele Rossetto, Sheref S. Mansy, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4756-4774
Open Access | Times Cited: 67
Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant Klebsiella pneumoniae in mice
Qingqing Fang, Yu Feng, Alan McNally, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 56
Qingqing Fang, Yu Feng, Alan McNally, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 56
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world
Tobi E. Nagel, Lillian Musila, Milkah Muthoni, et al.
Current Opinion in Virology (2022) Vol. 53, pp. 101208-101208
Open Access | Times Cited: 44
Tobi E. Nagel, Lillian Musila, Milkah Muthoni, et al.
Current Opinion in Virology (2022) Vol. 53, pp. 101208-101208
Open Access | Times Cited: 44
Phage Products for Fighting Antimicrobial Resistance
Yuanling Huang, Wenhui Wang, Zhihao Zhang, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1324-1324
Open Access | Times Cited: 43
Yuanling Huang, Wenhui Wang, Zhihao Zhang, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1324-1324
Open Access | Times Cited: 43
Current Promising Strategies against Antibiotic-Resistant Bacterial Infections
Jin-zhou Ye, Xinhai Chen
Antibiotics (2022) Vol. 12, Iss. 1, pp. 67-67
Open Access | Times Cited: 39
Jin-zhou Ye, Xinhai Chen
Antibiotics (2022) Vol. 12, Iss. 1, pp. 67-67
Open Access | Times Cited: 39
Revisiting therapeutic options against Resistant Klebsiella Pneumoniae infection: phage therapy is key
Jiabao Xing, Rong-jia Han, Jinxin Zhao, et al.
Microbiological Research (2025), pp. 128083-128083
Closed Access | Times Cited: 1
Jiabao Xing, Rong-jia Han, Jinxin Zhao, et al.
Microbiological Research (2025), pp. 128083-128083
Closed Access | Times Cited: 1
Contribution of Podoviridae and Myoviridae bacteriophages to the effectiveness of anti-staphylococcal therapeutic cocktails
Maria Kornienko, NS Kuptsov, RB Gorodnichev, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Maria Kornienko, NS Kuptsov, RB Gorodnichev, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy
Luigi Marongiu, Markus Burkard, Ulrich M. Lauer, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 4
Open Access | Times Cited: 30
Luigi Marongiu, Markus Burkard, Ulrich M. Lauer, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 4
Open Access | Times Cited: 30
The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
Stephen Chijioke Emencheta, Chinasa Valerie Olovo, Osita C. Eze, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 19
Stephen Chijioke Emencheta, Chinasa Valerie Olovo, Osita C. Eze, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 19
Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae
Mengshi zhao, Hongru Li, Dehao Gan, et al.
mSystems (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 6
Mengshi zhao, Hongru Li, Dehao Gan, et al.
mSystems (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 6
Efficacy of Individual Bacteriophages Does Not Predict Efficacy of Bacteriophage Cocktails for Control of Escherichia coli O157
Yan D. Niu, Hui Liu, Hechao Du, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 40
Yan D. Niu, Hui Liu, Hechao Du, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 40
Therapeutic Effect of a Newly Isolated Lytic Bacteriophage against Multi-Drug-Resistant Cutibacterium acnes Infection in Mice
Ho Yin Pekkle Lam, Meng‐Jiun Lai, Ting‐Yu Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7031-7031
Open Access | Times Cited: 39
Ho Yin Pekkle Lam, Meng‐Jiun Lai, Ting‐Yu Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7031-7031
Open Access | Times Cited: 39
Magistral Phage Preparations: Is This the Model for Everyone?
Jean‐Paul Pirnay, Gilbert Verbeken
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S360-S369
Open Access | Times Cited: 14
Jean‐Paul Pirnay, Gilbert Verbeken
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S360-S369
Open Access | Times Cited: 14
A Klebsiella-phage cocktail to broaden the host range and delay bacteriophage resistance both in vitro and in vivo
Huanchang Chen, Haifeng Liu, Yanchun Gong, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Huanchang Chen, Haifeng Liu, Yanchun Gong, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Diet, microbiome, and probiotics establish a crucial link in vaccine efficacy
Soumam Dutta, Niloy Chatterjee, Nicholas L. F. Gallina, et al.
Critical Reviews in Microbiology (2025), pp. 1-26
Open Access
Soumam Dutta, Niloy Chatterjee, Nicholas L. F. Gallina, et al.
Critical Reviews in Microbiology (2025), pp. 1-26
Open Access
Characterization of a new lytic bacteriophage (vB_KpnM_KP1) targeting Klebsiella pneumoniae strains associated with nosocomial infections
José Molina-López, Berenice Simon-Olea, María del Rosario Espinoza-Mellado, et al.
Virology (2025), pp. 110526-110526
Open Access
José Molina-López, Berenice Simon-Olea, María del Rosario Espinoza-Mellado, et al.
Virology (2025), pp. 110526-110526
Open Access
Viruses of protozoan parasites and viral therapy: Is the time now right?
Paul Barrow, Jean‐Claude Dujardin, Nicolás Fasel, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Paul Barrow, Jean‐Claude Dujardin, Nicolás Fasel, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 37